332 related articles for article (PubMed ID: 28641154)
1. Serum albumin-adjusted glycated albumin as a better indicator of glycemic control in Type 2 diabetes mellitus patients with short duration of hemodialysis.
Yajima T; Yajima K; Hayashi M; Takahashi H; Yasuda K
Diabetes Res Clin Pract; 2017 Aug; 130():148-153. PubMed ID: 28641154
[TBL] [Abstract][Full Text] [Related]
2. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
[TBL] [Abstract][Full Text] [Related]
3. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
4. Distinct biomarker roles for HbA
Hayashi A; Takano K; Masaki T; Yoshino S; Ogawa A; Shichiri M
J Diabetes Complications; 2016; 30(8):1494-1499. PubMed ID: 27614726
[TBL] [Abstract][Full Text] [Related]
5. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
[TBL] [Abstract][Full Text] [Related]
6. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
[TBL] [Abstract][Full Text] [Related]
7. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.
Kumeda Y; Inaba M; Shoji S; Ishimura E; Inariba H; Yabe S; Okamura M; Nishizawa Y
Clin Endocrinol (Oxf); 2008 Oct; 69(4):556-61. PubMed ID: 18248645
[TBL] [Abstract][Full Text] [Related]
8. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
10. Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetes.
Yamada S; Inaba M; Shidara K; Okada S; Emoto M; Ishimura E; Nishizawa Y
Life Sci; 2008 Sep; 83(13-14):516-9. PubMed ID: 18760286
[TBL] [Abstract][Full Text] [Related]
11. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
[TBL] [Abstract][Full Text] [Related]
12. Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis.
Ueda S; Nagai K; Yokota N; Hirose D; Mori H; Noma Y; Doi T; Minakuchi J
J Artif Organs; 2019 Sep; 22(3):264-267. PubMed ID: 30805746
[TBL] [Abstract][Full Text] [Related]
13. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
[TBL] [Abstract][Full Text] [Related]
14. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
[TBL] [Abstract][Full Text] [Related]
15. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis.
Freedman BI; Shenoy RN; Planer JA; Clay KD; Shihabi ZK; Burkart JM; Cardona CY; Andries L; Peacock TP; Sabio H; Byers JR; Russell GB; Bleyer AJ
Perit Dial Int; 2010; 30(1):72-9. PubMed ID: 20056983
[TBL] [Abstract][Full Text] [Related]
16. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
[TBL] [Abstract][Full Text] [Related]
17. Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis?
Abe M; Hamano T; Hoshino J; Wada A; Inaba M; Nakai S; Masakane I
Diabetes Res Clin Pract; 2017 Aug; 130():211-220. PubMed ID: 28648854
[TBL] [Abstract][Full Text] [Related]
18. Correlations Between Glycemic Parameters Obtained from Continuous Glucose Monitoring and Hemoglobin A1c and Glycoalbumin Levels in Type 2 Diabetes Mellitus.
Sonoda S; Okada Y; Torimoto K; Sugai K; Uemura F; Tanaka K; Hajime M; Mori H; Tanaka Y
J UOEH; 2020; 42(4):299-306. PubMed ID: 33268606
[TBL] [Abstract][Full Text] [Related]
19. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis.
Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM
Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952
[TBL] [Abstract][Full Text] [Related]
20. Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study.
Lu JM; Ji LN; Li YF; Li QM; Lin SS; Lv XF; Wang L; Xu Y; Guo XH; Guo QY; Ma L; Du J; Chen YL; Zhao CL; Zhang QL; She QM; Jiao XM; Lu MH; Pan RQ; Gao Y
J Diabetes Complications; 2016; 30(8):1609-1613. PubMed ID: 27496253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
